Madison, Wis. - Gov. Jim Doyle and Kikkoman Corp. Chairman and Chief Executive Officer Yuzaburo Mogi today marked the establishment of Kikkoman USA's new research and development laboratory in University Research Park. They were joined by a host of state and local officials, including...
With all the drug discoveries being reported around the globe, the U.S. Food and Drug Administration is becoming the world's prevailing regulatory authority for the approval of healthcare products, notes columnist Michael Rosen. In this edition of Yer Biotech Blues, Rosen says a truly harmonized...
http://www.madison.com/wsj/home/biz/303722 ...
NeoStem, Inc., which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells, today announced that the Company's CEO, Robin Smith, M.D., MBA, has been invited to participate at the World Stem Cell Summit on September 22-23, 2008 on a panel to...
http://www.jsonline.com/story/index.aspx?id=791541 ...
Milwaukee, Wis. - The Medical College of Wisconsin in Milwaukee has received a five-year, $3,082,752 renewal grant from the National Cancer Institute to continue to develop the College's Center for International Blood and Marrow Transplant Research (CIBMTR) as a unique world resource of data and...
Milwaukee, Wis. - Prodesse, Inc. announced today the commercial release of its CE Marked ProParaflu+ Assay for European and other customers outside the U.S. It is also now available in the US as a Research Use Only product for non-clinical use. ProParaflu+ rapidly and accurately...
MPP Group, LLC, a Milwaukee-based pharmaceutical development start up, will receive $630,000 in grants and loans from the state to help cover its early-stage costs. MPP Group, which was founded in 2007, develops active pharmaceutical agents that are used to treat a variety of medical...
Everyone has heard of stem cell research pioneer James Thomson, but the full array of Wisconsin's scientific talent will be on display next month during the annual World Stem Cell Summit in Madison. Names like Clive Svendsen, Timothy Kamp, and Alta Charro also are likely...
America's economic malaise is dampening the ability of biotech companies to raise money from the financial markets, a traditional source of biotech capital, according to Yer Biotech Blues columnist Michael Rosen. Fortunately, something is sustaining the biotech industry, and that something is the voracious appetite...